Estimating long-term treatment effects without long-term outcome data

David Rhys Bernard (Paris School of Economics)

GPI Working Paper No. 11-2020

This paper has been awarded the paper prize of the 2019 Early Career Conference Programme.

Estimating long-term impacts of actions is important in many areas but the key difficulty is that long-term outcomes are only observed with a long delay. One alternative approach is to measure the effect on an intermediate outcome or a statistical surrogate and then use this to estimate the long-term effect. Athey et al. (2019) generalise the surrogacy method to work with multiple surrogates, rather than just one, increasing its credibility in social science contexts. I empirically test the multiple surrogates approach for long-term effect estimation in real-world conditions using long-run RCTs from development economics. In the context of conditional cash transfers for education in Colombia, I find that the method works well for predicting treatment effects over a 5-year time span but poorly over 10 years due to a reduced set of variables available when attempting to predict effects further into the future. The method is sensitive to observing appropriate surrogates.

Other working papers

In defence of fanaticism – Hayden Wilkinson (Australian National University)

Consider a decision between: 1) a certainty of a moderately good outcome, such as one additional life saved; 2) a lottery which probably gives a worse outcome, but has a tiny probability of a far better outcome (perhaps trillions of blissful lives created). Which is morally better? Expected value theory (with a plausible axiology) judges (2) as better, no matter how tiny its probability of success. But this seems fanatical. So we may be tempted to abandon expected value theory…

High risk, low reward: A challenge to the astronomical value of existential risk mitigation – David Thorstad (Global Priorities Institute, University of Oxford)

Many philosophers defend two claims: the astronomical value thesis that it is astronomically important to mitigate existential risks to humanity, and existential risk pessimism, the claim that humanity faces high levels of existential risk. It is natural to think that existential risk pessimism supports the astronomical value thesis. In this paper, I argue that precisely the opposite is true. Across a range of assumptions, existential risk pessimism significantly reduces the value of existential risk mitigation…

Meaning, medicine and merit – Andreas Mogensen (Global Priorities Institute, Oxford University)

Given the inevitability of scarcity, should public institutions ration healthcare resources so as to prioritize those who contribute more to society? Intuitively, we may feel that this would be somehow inegalitarian. I argue that the egalitarian objection to prioritizing treatment on the basis of patients’ usefulness to others is best thought…